Td Private Client Wealth »

Atrium Therapeutics shares owned by Td Private Client Wealth

Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by Td Private Client Wealth from 13F filings

Historical chart of Td Private Client Wealth investment in Atrium Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atrium Therapeutics held by Td Private Client Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atrium Therapeutics by Td Private Client Wealth

Quarter filed Position value Share count Share price at filing
2026-06-30 $994 74 13.45

More positions owned by Td Private Client Wealth

Spdr Ser Tr State Str Spdr Port S&p 500 Etf Exchange Traded Fund (SPYM)
Ishares Tr Core Msci Eafe Etf Exchange Traded Fund (IEFA)
Vanguard Scottsdale Fds Vanguard Mtg Backed Secs Etf Exchange Traded Fund (VMBS)
State Str Spdr S&p 500 Etf Tr Tr Unit Exchange Traded Fund (SPY)
Ishares Tr U S Treas Bd Etf Exchange Traded Fund (GOVT)
Vanguard Index Fds Vanguard Extended Mkt Etf Exchange Traded Fund (VXF)
Ishares Tr Core Divid Growth Etf Exchange Traded Fund (DGRO)
Ishares Tr 5-10 Yr Invt Grade Corporate Bd Etf Exchange Traded Fund (IGIB)
Vanguard Admiral Fds Inc S&p 500 Growth Index Fd Etf Exchange Traded Fund (VOOG)
Vanguard Scottsdale Fds Vanguard Short-term Treas Index Exchange Traded Fund (VGSH)
Vanguard Specialized Funds Divid Appreciation Etf Exchange Traded Fund (VIG)
Ishares Inc Core Msci Emerging Mkts Etf Exchange Traded Fund (IEMG)
ISHARES TR 20 plus YR TREAS BD ETF Exchange Traded Fund (TLT)
Ishares Tr 1-3 Yr Treas Bd Etf Exchange Traded Fund (SHY)
Ishares Tr Msci Eafe Etf Exchange Traded Fund (EFA)

View all positions for Td Private Client Wealth

Top funds holding Atrium Therapeutics

T. Rowe Price Associates
Sessa Capital IM
BlackRock
Susquehanna International
Vanguard Capital Management
CRCM
TIG Advisors
Geode Capital Management
Two Sigma Investments
Goldman Sachs Group
683 Capital Management
Fort Hoosac Management
State Street Corporation
Cantor Fitzgerald, L. P.
Slotnik Capital

View all funds holding Atrium Therapeutics